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Objective: To evaluate whether T2 and T1r relaxation times of knee cartilage determined with 3T
magnetic resonance imaging (MRI) at baseline predict longitudinal progression of cartilage degenerative
changes.
Methods: Quantitative analysis of cartilage was performed using 3T MRI with both T2 and T1r mapping
techniques in 55 subjects without evidence of severe osteoarthritis (OA) [KellgreneLawrence (KL) score
of 0e3] at baseline. Morphological abnormalities of cartilage, menisci, ligaments and bone marrow were
analyzed on sagittal fat-saturated intermediate-weighted fast spin echo (FSE) sequences. Progression of
degenerative changes was analyzed over a period of 2 years. Progression was detected in 27 subjects
while in 28 subjects no changes were found. Differences between T2 and T1r relaxation times in these
two cohorts were compared using one-way analysis of variance (ANOVA) and t tests.
Results: Baseline T2 and T1r values were signiﬁcantly higher in the progression cohort in all compart-
ments (P < 0.05) except the lateral tibia (LT) for T2 and the medial tibia (MT) for T1r. Progression of
cartilage degenerative disease was most pronounced at the medial femoral condyles and at the femoro-
patellar joint; differences between the two cohorts for T2 and T1r were also most signiﬁcant in these
compartments.
Conclusions: T2 and T1r measurements were signiﬁcantly higher at baseline in individuals that showed
progression of cartilage abnormalities over a period of 2 years and may therefore serve as potential
predictors for progression of degenerative cartilage abnormalities in knee OA.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is traditionally characterized using
KellgreneLawrence (KL) scores1 on radiographs and presence of
clinical symptoms2. However by the time OA is recognized on
radiographs, it has progressed to a level that may force patients to
alter their lifestyles. Severe OA is the leading cause of chronic
disability among the elderly population in the United States2. Risk
factors include genetic predisposition, obesity3 and both very low
or very high levels of physical activity;4 the only preventative
measures noted aremeasures to minimize exposure to risk factors5.
Degenerative joint disease therapy of the knee includes self-
management (weight loss, exercise), symptomatic medicationo: T.M. Link, Department of
alifornia San Francisco, 400
4143-0628, USA. Tel: 1-415-
ad), Lorenzo.Nardo@ucsf.edu
er), Gabby.Joseph@ucsf.edu
@ucsf.edu (T.M. Link).
s Research Society International. P(analgesics or intra-articular corticosteroids), and in advanced
cases arthroplasty6.
Therapies such as knee braces or heel wedges have also been
suggested, however, not one single therapy is known to be effective
for all sufferers of OA. Guidelines from the American College of
Rheumatology (ACR) recommend both drug therapy and non-
pharmacologic interventions for patients with OA of the knee.
ACR conditionally recommends acetaminophen, oral or topical
non-steroidal antinﬂammatory drugs (NSAIDs), tramadol, or intra-
articular corticosteroid injections for the initial treatment of knee
OA5e8.
Studies have shown that quantitative MR T2 and T1r relaxation
time measurements can show changes in cartilage before abnor-
malities are visualized on radiographs andmorphological magnetic
resonance imaging (MRI)9e13. The extracellular matrix of the knee
cartilage is comprised mostly of proteoglycans and collagen and
water. Loss of proteoglycan molecules is an indicator of cartilage
degeneration and because T1r detects changes in proteoglycan
content of the cartilage, T1r is a viable tool for detecting early
degenerative disease of cartilage14. T2 has been shown to reﬂect the
ability of free water protons to move within the cartilage matrix;ublished by Elsevier Ltd. All rights reserved.
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the cartilage increase the T2 value, making it a viable biomarker for
early cartilage matrix degeneration11e13,15.
While T1r and T2 mapping techniques have been used for early
detection of biochemical changes in cartilage of the knee16, there is
limited information whether these measurements can predict
longitudinal progression of degenerative joint disease. The purpose
of this study was to evaluate whether T2 and T1r relaxation times of
knee cartilage determined with 3T MRI at baseline predict longi-
tudinal progression of cartilage degeneration.
Material and methods
Subjects
Subjects were recruited from the general public by advertise-
ment, or through referral from the Orthopedic Institute of the
University of California San Francisco. Subjects with self-reported
clinical symptoms at the knee consistent with OA and/or radio-
graphic evidence of OA and normal controls were studied. A total of
55 subjects (25 females and 30 males) with an age range of 25e
75 years (mean age 49.9  11.9) with radiographic KL scores
between 0 and 3 were studied. Table I shows the demographic
characteristics of our population along with KL and Western
Ontario and McMasters University (WOMAC) scores. MR images of
the knee were obtained in all subjects at baseline and 2-year
follow-up. Exclusion factors included severe OA or KL scores of 4
and lack of follow-up MRI.
The study was approved by the Committee on Human Research
at the University of California San Francisco. All subjects gave
informed written consent prior to the study. To quantify pain,
stiffness, and function in our cohort, subjects ﬁlled out the ﬁve-
point scale WOMAC questionnaires17,18.
MRI
MRIs were obtained with a 3T GE Excite Signa MR Scanner
(General Electric, Milwaukee, WI, USA) and an eight-channel
phased-array knee coil (In vivo, Orlando, FL, USA). Using accelera-
tion factor (AF)¼ 2, parallel imaging was used with an array spatial
sensitivity technique (ASSET), resulting in reduced imaging times. A
sagittal intermediate-weighted sequence with fat-suppression
(ﬁeld of view (FOV): 13e16 cm; slice thickness: 4 mm; repetition
time (TR): 4000 ms; echo time (TE): 40 ms) was obtained for the
clinical morphological evaluation. T2 and T1r (3D MAPPS-Table I
Demographic characteristics of the 55 subjects
Variables N (%) or mean  SD
Male 30 (54.5%)
Female 25 (45.4%)
Age (years) 50.5  10.2
Race
White 36 (65.5%)
Black 2 (3.6%)
Asian 13 (23.6%)
Other 4 (7.3%)
BMI (kg/m2) 28.7  4.3
KL score
0 20 (36.4%)
1 14 (25.5%)
2 10 (18.2)
3 11 (20.0%)
WOMAC
Pain 4.1  4.3
Stiffness 2.1  2.0
Function 13.2  14.0magnetization-prepared angle-modulated partitioned-k-space
Spoiled Gradient Recalled (SPGR) snapshot)19,20 sequence param-
eters are presented in detail in Table II. Morphologic MR studies
were obtained at baseline and 2 years.
MR image analysis
Radiological progression
Baseline and follow-up MR images were reviewed by an expe-
rienced musculoskeletal radiologist (TML) without knowledge of
clinical or radiographic ﬁndings in all subjects. Cartilage abnor-
malities at baseline were compared with those shown in the
follow-up studies on a picture archiving and communication
system (PACS) workstation (Agfa, Ridgeﬁeld Park, NJ, USA).
Progression was deﬁned as an increase in depth or width of
a cartilage lesion over a period of a minimum of 2 years. Presence of
new lesions (incidental lesions) was also deﬁned as disease
progression. The increase in depth was deﬁned as mild (resulting in
less than 50% cartilage thickness change) or severe (resulting in
more than 50% cartilage thickness change). The increase in width
was deﬁned as mild (less than 5 mm) or severe (more than 5 mm).
Severe change was diagnosed if either increase in depth and/or
width were graded as severe. Change in bone marrow edema
pattern and joint effusion/synovitis were not used to deﬁne
progression. Changes in meniscal lesions were not observed in our
cohort.
Based on radiographic evidence of OA (KL > 1) at the baseline,
the progression and non-progression cohorts, distinguished onMRI
images, were further divided into four subcohorts: normal controls
showing no progression (NN), normal controls that progress (NP),
OA subjects showing no progression (OAN) and, OA subjects that
progress (OAP).
Morphological analysis
One of the most frequently used classiﬁcations for scoring
degenerative abnormalities is thewhole-organmagnetic resonance
imaging score (WORMS)21 and a modiﬁed-WORMS classiﬁcation
has been introduced by our research group, tailored for assessing
mild to moderate abnormalities22,23. The modiﬁed-WORMS
University of California, San Francisco (UCSF) classiﬁcation
reduces the number of the anatomical compartments from 15,
evaluated by the classic WORMS to six: lateral tibia (LT), trochlea
(T), medial tibia (MT), lateral femur (LF), medial femur (MF) and
patella (PAT). Using this semi-quantitative scoring system, cartilage
abnormalities were scored using an eight-point scale: 0 ¼ normal
thickness and signal; 1 ¼ normal thickness but abnormal signal on
ﬂuid sensitive sequences; 2.0 ¼ partial-thickness focal defect
<1 cm in greatest width; 2.5 ¼ full-thickness focal defect <1 cm in
greatest width; 3 ¼ multiple areas of partial-thickness (Grade 2.0)
defects intermixed with areas of normal thickness, or a Grade 2.0
defect wider than 1 cm but<75% of the region; 4¼ diffuse (75% of
the region) partial-thickness loss; 5 ¼ multiple areas of full-
thickness loss (Grade 2.5) or a Grade 2.5 lesion wider than 1 cm
but <75% of the region; 6 ¼ diffuse (75% of the region) full-
thickness loss. The WORMS max score was deﬁned as the
maximum of theWORMS scores in all compartments per patient, in
addition WORMS average scores were calculated. All WORMS
readings were performed by two board-certiﬁed radiologists (TML,
LN).
Quantitative analysis
To determine T1r and T2 relaxation time measurements images
were analyzed on Sun Workstations (Sun Microsystems, Palo Alto,
CA, USA). Segmentation of cartilage compartments [lateral femoral
condyle (LFC), medial femoral condyle (MFC), PAT, LT, MT] was
Table III
Subject characteristics stratiﬁed by progression and non-progression
Age
(years)
BMI
(kg/m2)
WOMAC
pain
WOMAC
stiffness
WOMAC
function
Number of
subjects
Progressors
Mean* 52.55 26.55 3.96 2.62 13.37 Males ¼ 13
SD* 10.44 5.08 3.64 2.95 13.20 Females ¼ 14
Non-progressors
Mean 47.32 24.70 3.96 1.89 12.32 Males ¼ 17
SD 13.42 3.88 4.93 2.02 15.89 Females ¼ 11
P-value 0.1135 0.1356 0.999 0.2875 0.7908 n/a
*Means and SDs of the two cohorts were not signiﬁcantly different in this study.
Table II
Parameters of SPGR, T2 and T1r MRI sequences
Sequence TR (ms) TE (ms) FOV Matrix Slice
thickness
(mm)
Bandwidth
(KHz)
Parameter Acquisition time
SPGR (ﬂip angle ¼ 12) 15 6.7 14 512  512 1 31.25 Cartilage volume
and thickness
6 min
Fast spin echo (FSE) 4300 51 14 512  256 2.5
(0.5 gap)
e WORMS e
3D T1r* (TSL ¼ 0/10/40/80 ms,
FSL ¼ 500 Hz)
9.3 3.7 14 256  192 3 e T1r 8 min
3D T2 9.3 3.1/13.5/23.9/44.8 14 256  192 3 e T2 8 min
* Recovery time 1200 ms.
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ware (utilizing edge detection and Bezier splines) developed in
Matlab (Mathworks, Natick, MA, USA); segmentation was semi-
automatic and performed by two individuals (JS, AP) with prior
segmenting experience. Using the LevenbergeMarquardt mono-
exponential ﬁtting algorithm described by the equation below, T2
and T1r maps were generated:24
SðTSLÞfexp TSL=T1r

T1r

SðTEÞfexpðTE=T2ÞðT2Þ
The VTK CISG Registration Toolkit (T. Hartkens, London, UK) was
used to rigidly register the generated reconstructed maps to the
SPGR images. Segmentations derived from SPGR images were
registered to the ﬁrst echo. The rotations and translations from this
registration were applied to the ﬁtted T1r and T2 maps, in order to
extract quantitative data. For each compartment, T1 rho and T2
values were calculated on a pixel-by-pixel basis, and then averaged
over the region of interest (ROI).
Statistical analysis
Statistics were calculated using JMP software, version 9.0 (SAS
Institute, Cary, NC, USA). Using one-way analysis of variance
(ANOVA), differences in both T2 and T1r relaxation times by
cartilage compartment were assessed between progression and
non-progression cohorts. P-values of < 0.05 were considered
signiﬁcant. Outliers were eliminated using Chauvenet’s criterion
(values more than two standard deviations (SDs) from the mean
were excluded)25.
Two outliers were found for T1r baseline values: one in the LFC
and one in the MT and no outliers were found at baseline for T2
values based on the Chauvenet’s criteria.
Student’s t test was also performed by compartment and where
t test and ANOVA results were signiﬁcant, a post-hoc Tukeye
Kramer Honestly Signiﬁcant Differences (HSD) test was per-
formed. In addition, nominal logistic regression models were used
to assess the relationship between T2 and T1r vs morphologic
progression.
Results
Subject characteristics
Table III shows the subject characteristics stratiﬁed by
progression e there was no signiﬁcant difference between age,
body mass index (BMI), gender, or WOMAC scores of progressors
(n ¼ 27) and non-progressors (n ¼ 28). Linear regression was per-
formed with age, BMI, WOMAC scores, and gender. Although age,
BMI, and WOMAC scores showed a trend (increased values wereassociated with progression), no signiﬁcant associations were
found (P > 0.05). Females tended to progress more frequently (56%
of females progressed whereas only 43% of males progressed) but
differences were not signiﬁcant (P > 0.05). Of the progression
group, there were eight subjects who had KL grade 0 on radio-
graphs, seven had KL grade 1, ﬁve had KL grade 2 and seven subjects
had KL grade 3; in the non-progressors there were 12 subjects with
KL grade 0, seven had KL grade 1, ﬁve had KL grade 2 and four had
KL grade 3.Morphological ﬁndings: WORMS analysis
At baseline the non-progression cohort, stratiﬁed by WORMS
maximum score was characterized by 14 subjects with a score
equal to 0 or 1, four subjects had a score of 2, three subjects a score
of 3 and seven had a score of 5. In the progression cohort nine
subjects had a score equal to 0 or 1, six subjects had a score of 2, one
of 2.5, three of 3, six of 5 and two of 6. WORMS average scores were
2.1 and 2.6 for the non-progression and progression cohorts,
respectively. Though higher scores in the progression cohort
appeared more frequent and average scores were higher, no
statistical signiﬁcant difference in WORMS was noted between the
two cohorts (P ¼ 0.07).Progression vs non-progression criteria analysis
In total 35 progressive lesions were found as demonstrated in
Table IV. Ten of the 35 lesions were new lesions characterized by
partial-thickness cartilage loss and a width less than 1 cm. The
other 25 lesions were characterized by increase in width and/or
depth of pre-existing lesions. Two of these lesions showed severe
progression in both width (more than 1 cm) and depth, while 13
out of 25 showed a mild progression in both depth (none become
a full-thickness lesion) and width (less than 5 mm). Ten lesions had
a mild increase in width (less than 5 mm) without any increase in
depth. Figure 1 shows an example of progressive lesions after
2 years of follow-up.
Fig. 2. Dot plot showing T2 relaxation time values, stratiﬁed by progression vs non-
progression. SDs are also depicted, asterisks (*) indicate statistical signiﬁcance
between the two groups (P < 0.05).
Table IV
Summary of lesion location and type within the progression cohort
Compartments Lesion # New lesions
(incidental lesion)
Increase of
pre-existing
(prevalent) lesion
MFC 14 5 9
MT 2 e 2
PAT 10 3 7
T 9 2 7
LFC 0 0 0
LT 0 0 0
Total 35 10 25
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over the 2 years follow-up: 12 at the MF, four at the PAT and ﬁve at
the T. Six subjects developed multiple lesions: in two subjects the
lesions involved MF, MT and PAT compartments and in four both
PAT and T compartments.
T2 relaxation
Statistically signiﬁcant higher baseline T2 values were found in
the progression compared to the non-progression cohort in all
compartments (P < 0.05) except for the LT (P ¼ 0.21; Fig. 2).
Statistical signiﬁcance was noted in the MFC (P ¼ 0.0.03), MT
(P ¼ 0.02), LFC (P ¼ 0.01), and PAT (P ¼ 0.02). When examining the
individual compartments of the subjects in the progression cohort,
seven compartments (three LFC, one LT, one MFC, one MT and one
PAT) in ﬁve different subjects had baseline T2 values 1 SD below
themean (in the bottom 16th percentile of all observed values). The
logistic regression analysis demonstrated that elevated T2 values in
the LFC [odds ratio (OR): 2.62, P¼ 0.02], LT (OR: 1.58, P¼ 0.15), MFC
(OR: 2.12, P ¼ 0.03), MT (OR: 2.12, P ¼ 0.02) and PAT (OR: 2.20,
P ¼ 0.02) compartments were predictive of morphologic progres-
sion. Table V shows consistent results with higher ORs for indi-
viduals with progression for one SD increase in baseline T2 values.
However, no statistically signiﬁcant differences in T2 values were
found when assessing the progression cohort subgroups with
incident lesions, mild and severe progression of preexistentFig. 1. Sagittal, intermediate-weighted MR images demonstrate progression of a cartilage le
inferior pole of the patella (short arrow) associated with bone marrow edema is seen and at
site (long arrow).cartilage defects were compared (P > 0.05). Figure 3 shows an MR
color map of a subject with non-progressive changes and low T2
values (a-b-c) as well as high T2 values in a subject with progressive
disease (d-e-f).T1r relaxation
For T1r values, statistically signiﬁcant higher values were also
noted in the progression cohort compared to the non-progression
cohort in all compartments except the MT (P ¼ 0.12), Fig. 4.
Statistical signiﬁcance was noted in the MFC (P < 0.01), LFC
(P ¼ 0.03), LT (P ¼ 0.01), and PAT (P ¼ 0.01). When examining the
individual compartments of the subjects of the progression cohort,
14 compartments (two LFC, four LT, two MFC, two MT and threesion at the PAT: at baseline (a) a small amount of partial-thickness cartilage loss at the
the 12 month-follow-up (b) extensive full-thickness cartilage loss is shown at the same
Table V
ORs for one SD change in T2 and T1r
MFC MT LFC LT PAT
OR for one SD change in T2 2.12 2.12 2.616 1.58 2.19
OR for one SD change in T1r 2.71 1.79 2.15 1.97 2.28
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themean (in the bottom 16th percentile of all observed values). The
logistic regression analysis demonstrated that baseline T1r values
were associated with morphologic joint progression, in LFC (OR:
2.15, P ¼ 0.01), LT (OR: 1.97, P ¼ 0.03), MFC (OR: 2.71, P < 0.01), MT
(OR: 1.79, P ¼ 0.05) and PAT (OR: 2.28, P ¼ 0.014).
Again, there were no statistically signiﬁcant differences in T1r
values in the progression cohort between the subgroups with
incident lesions, mild and severe progression of preexistent carti-
lage defects.
Figure 5 shows MR color maps with low T1r values in a subject
with non-progressive changes (a-b-c) and high T1r values in
a subject with progressive disease (d-e-f).Fig. 4. Dot plot showing T1r relaxation time values, stratiﬁed by progression vs non-
progression. SDs are also depicted, asterisks (*) indicate statistical signiﬁcance
between the two groups (P < 0.05).T1r relaxation and T2 relaxation in different subcohorts
Based on radiographic evidence of OA (KL > 1) at baseline and
MRI criteria of progression/non-progression, the population was
divided into four subcohorts: 19 subjects in the NN subcohort, 15
subjects in the NP subcohort, nine in the OAN subcohort and 12 in
the OAP subcohort.
Statistically signiﬁcant lower baseline T2 values were found in
the NN subcohort compared to the OAP subcohort in allFig. 3. Sagittal T2 color maps (a, d) with baseline (b, e) and follow-up (c, f) sagittal intermed
both at the baseline (b) and at the follow-up (c) (non-progressor). High T2 values (d) are
(e) partial femoral and tibial cartilage defects at baseline (arrow) progress in the follow-up
In addition new bone marrow edema pattern is shown at the femur and tibia (short arrowcompartments except the LT: MFC (P < 0.01), MT (P < 0.01), LFC
(P ¼ 0.02), LT (P ¼ 0.12) and PAT (P < 0.01). For T1r, statistically
signiﬁcant lower values were also noted in the NN subcohort
compared to the OAP subcohort in all compartments: MFC
(P< 0.01), MT (P¼ 0.04), LFC (P< 0.01), LT (P< 0.01), PAT (P< 0.01).
No other statistically signiﬁcant differences were found throughout
all compartments in the remaining subcohorts.iate-weighted MR images. Low T2 values (a) are associated with intact patella cartilage
associated with extensive progression of femoral and tibial cartilage degeneration:
(f) with full-thickness loss and partial-thickness cartilage loss at the tibia (long arrow).
).
Fig. 5. Sagittal T1r color maps (a,d) with baseline (b,e) and follow-up (c,f) sagittal morphological MR images. In (a) the T1r color map demonstrates low patellar T1r values at baseline
(average value 30). Baseline (b) and follow-up (c) depict intact patellar cartilage with no degeneration (c). In (d) the T1r color map shows high patellar values at baseline (average
value about 40). Baseline (e) and follow-up (f) demonstrate progression of a cartilage lesion at the patella: at baseline mild ﬁssuring of the cartilage at the patella is shown (short
arrow) associated with bone marrow edema pattern (long arrow) and at the follow-up (f) progression to extensive full-thickness cartilage loss is noted at this site (arrow).
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The results of our study show that quantitative T2 and T1r
relaxation time measurements predict the progression of cartilage
degeneration in the knee, assessed with 3T MRI. Both T2 and T1r
were able to separate progression and non-progression cohorts and
the percentage differences as well as the ORswere also comparable.
To the best of our knowledge this is the ﬁrst study to demonstrate
that both T2 and T1r relaxation time measurements maybe suitable
to predict morphological progression of cartilage degenerative
disease.
Clinical ﬁndings
Our ﬁnding that females showed more overall progression than
males, though not signiﬁcant, is similar to ﬁndings of other studies:
Vavken et al. found a 0.63 ratio of gender difference in incidence of
OA. AlsoMcAlindon et al.26 demonstrated a higher prevalence of OA
in women especially for the PAT-femur compartment where the
prevalence in women older than 55 years was 8% and in men
population was 2%. In our study clinical features were not signiﬁ-
cantly associated with progression and incidence of severe disease,
which is also consistent with other studies: Link et al.27 did not ﬁnd
consistent correlations between pain and radiographic and MRI
ﬁndings of OA (cartilaginous, ligamentous, and meniscal abnor-
malities) or between pain and radiographic grades that are used to
assess OA. Kornaat et al. also suggested that focal or diffuse carti-
laginous abnormalities were not associated with pain but associ-
ated with larger joint effusion and osteophytes28.Morphological ﬁndings
The baselineWORMS values did not show signiﬁcant differences
between progression and non-progression cohorts. The limited
sample of subjects may explain these results, which were border-
line signiﬁcant and demonstrated a statistical trend, with the
progression cohort having higher scores, consistent with prior
work which describes a positive association between severity and
progression of lesions13,29. However, in this same sample, T1r and T2
were able to predict the morphological progression with statistical
signiﬁcance, thereby emphasizing the importance of these
biochemical biomarkers.
A majority of our subjects showed more progression at the
medial tibio-femoral compartment and at the PAT-femoral
compartments than at the lateral femoral compartment. According
to the literature, these two compartments are more frequently
affected by OA of the knee26,30. Although these two compartments
display similar pathological trends with regard to OA, their biome-
chanical, biochemical properties, along with risk factors, will starkly
differ. Speciﬁc risk factors for femoro-patellar OA are patellar mala-
lignment (lateral patellar tilt or lateral dislocation or PAT tracking)
and muscle weakness. Risk factors for tibio-femoral include BMI,
varus/valgus malalignment and gait disorders31. The common path-
ogenesis of those causes is an increased stress at the articulation,
which leads progressively to the degeneration of the cartilage with
associated joint space narrowing. Squatting and kneeling have no
relation with tibio-femoral OA but are strongly associated with PAT-
femoral OA32. The compartment that displayed limited progression
in our study was the lateral tibio-femoral joint compartment. This
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associated with OA in other studies30,32.
Quantitative ﬁndings
Previous studies have demonstrated that T2 and T1r relaxation
times show biochemical changes at the knee cartilage in the
absence of radiographic or MR evidence33,34, however, limited
information is available whether they may also serve as predictors
of progression of cartilage degenerative disease. Studies have
shown that T2 is effective in detecting biochemical changes asso-
ciated with OA2,35. T2 values are associated with water content and
collagen within the cartilage matrix, and have been shown to
increase in moderate degenerative joint disease35. T2 relaxation
measurements have also been shown to increase with severity of
OA36. These previous ﬁndings are all consistent with our ﬁndings
that elevated T2 levels at baseline are associated with increased
progression of OA.
T1r relaxation time has been indicated in quantiﬁcation of
biochemical changes within the cartilage at the knee, displaying
sensitivity to the proteoglycan content in the extracellular
matrix37e39. Elevated T1r relaxation times are associated with OA in
the patellar and femoral cartilage37. This is consistent with our
ﬁndings of elevated T1r times in the patellar and femoral cartilage
within our progression cohort. We are not able to determine
whether T2 or T1r values better predict cartilage damage and future
studies will be necessary to clarify which technique is better suited
for predicting progression.
The comparison of subcohorts obtained using MRI and radio-
graphic criteria strengthened our results; in particular the
comparison between the NN and OAP subcohorts found again
statistically signiﬁcant difference for all knee-compartments when
T2 values were used as predictor of progression and in all knee-
compartments except for MT when T1r values were used as
predictor of progression of cartilage damage.
Both T1r and T2 values were demonstrated to be superior to the
modiﬁed-WORMS in predicting cartilage lesion progression. In the
literature the WORMS classiﬁcation has often been used as
a reference for detecting morphological cartilage lesions12,15, and
most of the studies need a long term follow-up to demonstrate
through WORMS that T1r and T2 values are reliable predictors of
cartilage lesion progression11,13. Our results showed that the new
and progression of cartilage lesions are earlier predicted by the T1r
and T2 biomarkers and themodiﬁed-WORMSmay conﬁrm this data
just with a longer follow-up.
The limitations of our study include a relatively small patient
population (especially for the subcohort analysis) and a variety of
degenerative disease ranging from normal knees to those with
moderate OA.Wewere unable, due to the small number of patients,
to exclude higher KL grades, or to focus on one speciﬁc grade with
our analysis. Our follow-up time was also relatively short as OA
related cartilage changes occur over a period of many years.
Another possible limitation of the study was the availability of just
one morphological sequence for the WORMS reading. The use of
only one plane may underestimate cartilage lesions especially at
patellar compartment. In this study, the deﬁnition of progression
was based onmorphological MR ﬁndings and not clinical ﬁndingse
although MR ﬁndings maybe more sensitive and objective for
measuring early signs of progression over shorter time periods.
Finally the registration was able to mitigate most of the motion
artifacts, which, however, persisted throughout all knee-compart-
ments in three subjects only for the T2 sequence.
In conclusion our study has shown signiﬁcant differences in
baseline T2 and T1r relaxation measurements between a cohort of
individuals with and without progression of degenerative cartilageMR lesions; progression could be predictedmeasuring T2 and T1r at
the femoral condyles and femoro-patellar joints, where progression
of disease was also most advanced. Based on these ﬁndings, T2 and
T1r relaxation times may serve as predictors of cartilage degener-
ative disease progression, and in a clinical setting, may potentially
have a role not only in identifying high-risk patients, but also in
more effectively recommending preventative strategies to protect
the cartilage in the joint to these patients. Future studies in larger
cohorts, with more homogeneous patient characteristics, with
clinical metrics of OA and longer follow-up times are clearly
warranted.
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